Discounted Cash Flow Rating
Neutral
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Buy
Price to Earnings Rating
Neutral
Analyst Rating
Sell
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Buy
Standard Deviation
Strong Sell
Williams %R
Strong Buy
Average Directional Index
Sell
Insider Trading
Neutral
Wall Street Data Solutions Rating
Neutral
B
Senti Biosciences, Inc. Common Stock (SNTI)
Biological Products, (no Disgnostic Substances)
Senti Biosciences Inc is a preclinical biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. Its lead product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated OR+NOT off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma. It also develops SENTI-401, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate colorectal cancer/CRC cells.
2 CORPORATE DRIVE, FIRST FLOOR
SOUTH SAN FRANCISCO, CA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
06/09/2022
Market Cap
10,806,393
Shares Outstanding
44,550,000
Weighted SO
44,545,186
Total Employees
N/A
Upcoming Earnings
N/A
Beta
2.7490
Last Div
0.0000
Range
1.52-8.48
Chg
0.0100
Avg Vol
766896
Mkt Cap
10806393
Exch
NASDAQ
Country
US
Phone
(650) 382-3281
DCF Diff
N/A
DCF
0.0000
Div Yield
0.0000
P/S
18.3782
EV Multiple
-0.7642
P/FV
0.2444
Div Yield %
0.0000
P/E
-0.1895
PEG
0.0098
Payout
0.0000
Current Ratio
4.8896
Quick Ratio
4.8896
Cash Ratio
1.7490
DSO
11585.0255
DIO
0.0000
Op Cycle
11585.0255
DPO
14.3244
CCC
11570.7011
Gross Margin
-50.1786
Op Margin
-156.3946
Pretax Margin
-133.7024
Net Margin
-96.8588
Eff Tax Rate
0.0299
ROA
-0.6553
ROE
-0.9109
ROCE
-1.1813
NI/EBT
0.7244
EBT/EBIT
0.8549
EBIT/Rev
-156.3946
Debt Ratio
0.4112
D/E
0.8096
LT Debt/Cap
0.4149
Total Debt/Cap
0.4474
Int Coverage
-82.6978
CF/Debt
-1.1875
Equity Multi
1.9687
Rec Turnover
0.0315
Pay Turnover
25.4809
Inv Turnover
0.0000
FA Turnover
0.0153
Asset Turnover
0.0068
OCF/Share
-9.2832
FCF/Share
-9.6938
Cash/Share
3.4689
OCF/Sales
-72.1820
FCF/OCF
1.0442
CF Coverage
-1.1875
ST Coverage
-9.5808
CapEx Coverage
-22.6121
Div&CapEx Cov
-22.6121
P/BV
0.2444
P/B
0.2444
P/S
18.3782
P/E
-0.1895
P/FCF
-0.2438
P/OCF
-0.2542
P/CF
-0.2542
PEG
0.0098
P/S
18.3782
EV Multiple
-0.7642
P/FV
0.2444
DPS
0.0000